GG
LLY icon

Gleason Group’s Eli Lilly LLY Stock Holding History

Gleason Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Buy
1,368
+25
+2% +$25.5K 0.14% 36
2026
Q1 		$1.24M Sell
1,343
-129
-9% -$131K 0.12% 39
2025
Q4 		$1.58M Sell
1,472
-74
-5% -$70.8K 0.16% 33
2025
Q3 		$1.18M Buy
1,546
+3
+0.2% +$2.23K 0.12% 39
2025
Q2 		$1.2M Buy
1,543
+3
+0.2% +$2.33K 0.13% 37
2025
Q1 		$1.27M Buy
1,540
+2
+0.1% +$1.66K 0.23% 32
2024
Q4 		$1.19M Sell
1,538
-711
-32% -$589K 0.21% 32
2024
Q3 		$1.99M Buy
2,249
+1
+0% +$899 0.36% 24
2024
Q2 		$2.04M Buy
2,248
+3
+0.1% +$2.4K 0.41% 21
2024
Q1 		$1.75M Buy
2,245
+2
+0.1% +$1.42K 0.37% 25
2023
Q4 		$1.31M Sell
2,243
-40
-2% -$23.3K 0.3% 27
2023
Q3 		$1.23M Buy
2,283
+5
+0.2% +$2.58K 0.32% 26
2023
Q2 		$1.07M Buy
2,278
+5
+0.2% +$2.1K 0.28% 34
2023
Q1 		$780K Buy
2,273
+331
+17% +$112K 0.22% 40
2022
Q4 		$710K Buy
1,942
+6
+0.3% +$2.13K 0.22% 43
2022
Q3 		$626K Buy
1,936
+6
+0.3% +$1.9K 0.22% 38
2022
Q2 		$626K Buy
1,930
+6
+0.3% +$1.8K 0.22% 40
2022
Q1 		$551K Buy
1,924
+7
+0.4% +$1.8K 0.16% 43
2021
Q4 		$530K Buy
1,917
+7
+0.4% +$1.77K 0.17% 47
2021
Q3 		$441K Buy
1,910
+6
+0.3% +$1.48K 0.16% 49
2021
Q2 		$437K Buy
1,904
+8
+0.4% +$1.61K 0.16% 50
2021
Q1 		$354K Buy
1,896
+7
+0.4% +$1.37K 0.14% 51
2020
Q4 		$319K Sell
1,889
-594
-24% -$88.7K 0.15% 52
2020
Q3 		$368K Sell
2,483
-206
-8% -$31.9K 0.21% 47
2020
Q2 		$441K Sell
2,689
-87
-3% -$13.4K 0.27% 41
2020
Q1 		$385K Sell
2,776
-35
-1% -$4.81K 0.3% 40
2019
Q4 		$369K Buy
+2,811
New +$326K 0.22% 45

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gleason Group's LLY Position: Q2 2026 in Review

Gleason Group increased its Eli Lilly (LLY) stake by 1.9% in Q2 2026, buying an estimated $25.5K and bringing the position to 1,368 shares worth $1.64M. The position accounts for 0.14% of the portfolio, ranked #36.

Gleason Group first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.04M in Q2 2024. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Gleason Group held 1,368 shares of Eli Lilly worth $1.64M as of Q2 2026.
  • Gleason Group bought 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
  • Eli Lilly made up 0.14% of Gleason Group's portfolio in Q2 2026, its #36 holding.
  • Gleason Group first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • Gleason Group's Eli Lilly position peaked at $2.04M in Q2 2024.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gleason Group's 13F filing for Q2 2026, filed 13 Jul 2026.